← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 18, 2017Last known activity
Apr 26, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 4 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT06249815CollaboratorPhase 4Apr 26, 2024
- NCT05970861Lead sponsorN/ASep 1, 2023
- NCT05970861Overall official - principal investigatorN/ASep 1, 2023
- NCT05970861Reponsible party - principal investigatorN/ASep 1, 2023
- NCT03669835Lead sponsorN/AMar 28, 2018
- NCT03572491CollaboratorPhase 3Sep 18, 2017
Details
- Last known activity
- Apr 26, 2024